News

Filter

Current filters:

USAOphthalmicsLegal

1 to 9 of 97540 results

First UK NICE highly specialized technologies guidance recommends Soliris

First UK NICE highly specialized technologies guidance recommends Soliris

28-01-2015

England’s health costs watchdog the National Institute for Health and care Excellence has today issued…

Alexion PharmaceuticalsBiotechnologyHematologyPricingRare diseasesRegulationSolarisUK

Fourth quarter Bristol-Myers Squibb results disappoint

Fourth quarter Bristol-Myers Squibb results disappoint

27-01-2015

Although the fourth quarter financial results from US drug major Bristol-Myers Squibb beat analyst estimates,…

Bristol-Myers SquibbFinancialPharmaceuticalUnited StatesUSA

Pfizer’s 4th-qtr 2014 beats forecasts, but guidance disappoints

Pfizer’s 4th-qtr 2014 beats forecasts, but guidance disappoints

27-01-2015

US pharma giant Pfizer today reported fourth-quarter 2014 earnings of $1.23 billion, and net earnings…

Corporate crimeDow Jones Industrial AverageFinancialPfizerPharmaceutical

Gedeon Richter enters license and distribution deal with Bayer

Gedeon Richter enters license and distribution deal with Bayer

27-01-2015

Hungary’s largest drugmaker Gedeon Richter says that it has entered into a license and distribution…

BayerEuropeGedeon RichterLicensingLisvyMarkets & MarketingPharmaceuticalReproductiveSouth AmericaWomen's Health

Shire receives fast-track designation from FDA for SHP609 in Hunter syndrome

Shire receives fast-track designation from FDA for SHP609 in Hunter syndrome

27-01-2015

Ireland-headquartered drugmaker Shire has received fast-track designation from the US Food and Drug Administration…

NeurologicalPharmaceuticalRegulationShireSHP609

US FDA approves Symplmed and Servier’s Prestalia

US FDA approves Symplmed and Servier’s Prestalia

27-01-2015

Privately-held US drugmaker Symplmed Pharmaceuticals says that the US Food and Drug Administration has…

Cardio-vascularPharmaceuticalPrestaliaRegulationServierSymplmedUSA

Tau-based vaccines could transform early Alzheimer’s treatment, says analyst

Tau-based vaccines could transform early Alzheimer’s treatment, says analyst

27-01-2015

While current treatments for Alzheimer’s disease are only able to ease symptoms temporarily, tau-based…

AC ImmuneBiotechnologycrenezumabEli LillygantenerumabJohnson & JohnsonMarkets & MarketingNeurologicalResearchRochesolanezumabVaccines

T-Bird Pharma appoints Sandy Pratt as chief financial officer

T-Bird Pharma appoints Sandy Pratt as chief financial officer

27-01-2015

Canadian medical marijuana therapy specialist T-Bird Pharma has appointed Sandy Pratt as chief financial…

BoardroomCanadaPharmaceuticalT-Bird Pharma

1 to 9 of 97540 results

COMPANY SPOTLIGHT

Parexel

Parexel

Back to top